Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.

Qinzhu YangHaofan HuangGuizhi ZhangNuoqing WengZhenkai OuMeili SunHuixing LuoXuhui ZhouYi GaoXiaobin Wu

Published in: Thoracic cancer (2023)

The combined model incorporating radiomic features and clinical CECT predictors helps to predict the response to anti-PD-1therapy in patients with ESCC.

Keyphrases

contrast enhanced
magnetic resonance imaging
computed tomography
diffusion weighted
magnetic resonance
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
dual energy
diffusion weighted imaging
stem cells
image quality